JWM
IRWD icon

Jeppson Wealth Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Jeppson Wealth Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,450
Closed -$13K – 277
2020
Q3 		$13K Buy
+1,450
New +$14.4K 0.01% 369

Other funds holding IRWD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Jeppson Wealth Management's IRWD Position: Q4 2020 in Review

Jeppson Wealth Management sold out of Ironwood Pharmaceuticals (IRWD) in Q4 2020, closing a stake of 1,450 shares — an estimated $13K sold.

Jeppson Wealth Management first reported a position in IRWD in Q3 2020 and held it in 1 quarter. The position peaked at $13K in Q3 2020. 199 funds tracked by Wall St. Rank hold IRWD as of Q4 2020.

  • Jeppson Wealth Management reported no remaining Ironwood Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • Jeppson Wealth Management sold 1,450 Ironwood Pharmaceuticals shares in Q4 2020, an estimated $13K.
  • Jeppson Wealth Management first reported a position in Ironwood Pharmaceuticals in Q3 2020 and held it in 1 quarter.
  • Jeppson Wealth Management's Ironwood Pharmaceuticals position peaked at $13K in Q3 2020.
  • 199 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2020.

Based on Jeppson Wealth Management's 13F filing for Q4 2020, filed 5 Mar 2021.